533 related articles for article (PubMed ID: 32661416)
1. The DNA methylation landscape of advanced prostate cancer.
Zhao SG; Chen WS; Li H; Foye A; Zhang M; Sjöström M; Aggarwal R; Playdle D; Liao A; Alumkal JJ; Das R; Chou J; Hua JT; Barnard TJ; Bailey AM; Chow ED; Perry MD; Dang HX; Yang R; Moussavi-Baygi R; Zhang L; Alshalalfa M; Laura Chang S; Houlahan KE; Shiah YJ; Beer TM; Thomas G; Chi KN; Gleave M; Zoubeidi A; Reiter RE; Rettig MB; Witte O; Yvonne Kim M; Fong L; Spratt DE; Morgan TM; Bose R; Huang FW; Li H; Chesner L; Shenoy T; Goodarzi H; Asangani IA; Sandhu S; Lang JM; Mahajan NP; Lara PN; Evans CP; Febbo P; Batzoglou S; Knudsen KE; He HH; Huang J; Zwart W; Costello JF; Luo J; Tomlins SA; Wyatt AW; Dehm SM; Ashworth A; Gilbert LA; Boutros PC; Farh K; Chinnaiyan AM; Maher CA; Small EJ; Quigley DA; Feng FY
Nat Genet; 2020 Aug; 52(8):778-789. PubMed ID: 32661416
[TBL] [Abstract][Full Text] [Related]
2. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
3. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
4. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
[No Abstract] [Full Text] [Related]
5. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Quigley DA; Dang HX; Zhao SG; Lloyd P; Aggarwal R; Alumkal JJ; Foye A; Kothari V; Perry MD; Bailey AM; Playdle D; Barnard TJ; Zhang L; Zhang J; Youngren JF; Cieslik MP; Parolia A; Beer TM; Thomas G; Chi KN; Gleave M; Lack NA; Zoubeidi A; Reiter RE; Rettig MB; Witte O; Ryan CJ; Fong L; Kim W; Friedlander T; Chou J; Li H; Das R; Li H; Moussavi-Baygi R; Goodarzi H; Gilbert LA; Lara PN; Evans CP; Goldstein TC; Stuart JM; Tomlins SA; Spratt DE; Cheetham RK; Cheng DT; Farh K; Gehring JS; Hakenberg J; Liao A; Febbo PG; Shon J; Sickler B; Batzoglou S; Knudsen KE; He HH; Huang J; Wyatt AW; Dehm SM; Ashworth A; Chinnaiyan AM; Maher CA; Small EJ; Feng FY
Cell; 2018 Jul; 174(3):758-769.e9. PubMed ID: 30033370
[TBL] [Abstract][Full Text] [Related]
6. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
[TBL] [Abstract][Full Text] [Related]
7. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.
Kamdar SN; Ho LT; Kron KJ; Isserlin R; van der Kwast T; Zlotta AR; Fleshner NE; Bader G; Bapat B
Clin Epigenetics; 2016; 8():32. PubMed ID: 26981160
[TBL] [Abstract][Full Text] [Related]
8. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
[TBL] [Abstract][Full Text] [Related]
9. Epigenomic alterations in localized and advanced prostate cancer.
Lin PC; Giannopoulou EG; Park K; Mosquera JM; Sboner A; Tewari AK; Garraway LA; Beltran H; Rubin MA; Elemento O
Neoplasia; 2013 Apr; 15(4):373-83. PubMed ID: 23555183
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
Beltran H; Romanel A; Conteduca V; Casiraghi N; Sigouros M; Franceschini GM; Orlando F; Fedrizzi T; Ku SY; Dann E; Alonso A; Mosquera JM; Sboner A; Xiang J; Elemento O; Nanus DM; Tagawa ST; Benelli M; Demichelis F
J Clin Invest; 2020 Apr; 130(4):1653-1668. PubMed ID: 32091413
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide plasma DNA methylation features of metastatic prostate cancer.
Wu A; Cremaschi P; Wetterskog D; Conteduca V; Franceschini GM; Kleftogiannis D; Jayaram A; Sandhu S; Wong SQ; Benelli M; Salvi S; Gurioli G; Feber A; Pereira MB; Wingate AM; Gonzalez-Billalebeitia E; De Giorgi U; Demichelis F; Lise S; Attard G
J Clin Invest; 2020 Apr; 130(4):1991-2000. PubMed ID: 32149736
[TBL] [Abstract][Full Text] [Related]
14. Enduring epigenetic landmarks define the cancer microenvironment.
Pidsley R; Lawrence MG; Zotenko E; Niranjan B; Statham A; Song J; Chabanon RM; Qu W; Wang H; Richards M; Nair SS; Armstrong NJ; Nim HT; Papargiris M; Balanathan P; French H; Peters T; Norden S; Ryan A; Pedersen J; Kench J; Daly RJ; Horvath LG; Stricker P; Frydenberg M; Taylor RA; Stirzaker C; Risbridger GP; Clark SJ
Genome Res; 2018 May; 28(5):625-638. PubMed ID: 29650553
[TBL] [Abstract][Full Text] [Related]
15. Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
Gerhauser C; Favero F; Risch T; Simon R; Feuerbach L; Assenov Y; Heckmann D; Sidiropoulos N; Waszak SM; Hübschmann D; Urbanucci A; Girma EG; Kuryshev V; Klimczak LJ; Saini N; Stütz AM; Weichenhan D; Böttcher LM; Toth R; Hendriksen JD; Koop C; Lutsik P; Matzk S; Warnatz HJ; Amstislavskiy V; Feuerstein C; Raeder B; Bogatyrova O; Schmitz EM; Hube-Magg C; Kluth M; Huland H; Graefen M; Lawerenz C; Henry GH; Yamaguchi TN; Malewska A; Meiners J; Schilling D; Reisinger E; Eils R; Schlesner M; Strand DW; Bristow RG; Boutros PC; von Kalle C; Gordenin D; Sültmann H; Brors B; Sauter G; Plass C; Yaspo ML; Korbel JO; Schlomm T; Weischenfeldt J
Cancer Cell; 2018 Dec; 34(6):996-1011.e8. PubMed ID: 30537516
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of prostate cancer.
McKee TC; Tricoli JV
Methods Mol Biol; 2015; 1238():217-34. PubMed ID: 25421662
[TBL] [Abstract][Full Text] [Related]
17. Methylome-wide Sequencing Detects DNA Hypermethylation Distinguishing Indolent from Aggressive Prostate Cancer.
Bhasin JM; Lee BH; Matkin L; Taylor MG; Hu B; Xu Y; Magi-Galluzzi C; Klein EA; Ting AH
Cell Rep; 2015 Dec; 13(10):2135-46. PubMed ID: 26628371
[TBL] [Abstract][Full Text] [Related]
18. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer.
Friedlander TW; Roy R; Tomlins SA; Ngo VT; Kobayashi Y; Azameera A; Rubin MA; Pienta KJ; Chinnaiyan A; Ittmann MM; Ryan CJ; Paris PL
Cancer Res; 2012 Feb; 72(3):616-25. PubMed ID: 22158653
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
